Free Elizabeth Holmes Group Defends Theranos Founder at Screening

The legal and cultural fallout of the Theranos scandal continues to generate headlines, most recently outside a film festival screening. During the New York Film Festival, members of an advocacy group known as Just Blood appeared outside the venue to distribute flyers, t-shirts, and promote a petition demanding the release of convicted Theranos founder Elizabeth Holmes. Holmes is currently serving an 11-year prison sentence following her high-profile conviction for fraud, stemming from false claims that her company could run hundreds of medical tests from a single drop of blood.

At the center of this unexpected campaign is Ryan Elhosseiny, the head of Just Blood. Elhosseiny claims to have rebuilt the defunct Theranos blood-testing technology from the ground up by analyzing trial exhibits and public patents. Speaking to reporters, he asserted that Holmes's original vision was entirely scientifically viable and that her convictions represent a miscarriage of justice. However, despite these bold claims, there are no independent or official scientific verifications confirming that Elhosseiny has successfully recreated a working version of the technology.

The demonstration coincided with the screening of the new A24 documentary titled 'You Can See Everything.' In the film, Holmes continues to maintain her innocence, arguing that her technology could eventually work, even as experts note that several required medical processes remain uninvented. The documentary also explores Elhosseiny's involvement, including prominent billboards placed in major US cities that utilized Holmes's famous likeness alongside Elhosseiny's branding, prompting investigation from the film's co-director Nathan Fielder.

Elhosseiny maintains that his digital and technical reconstruction, allegedly aided by advanced artificial intelligence tools, proves the core validity of Theranos's innovations. His online petition urges federal authorities to review the technical record and reconsider the fraud convictions. Yet, despite the theatrical protests and modest petition signatures, the mainstream scientific and legal consensus remains unchanged regarding the fraudulent nature of Theranos's operations during its peak years.

The ongoing fascination with Elizabeth Holmes highlights the enduring public interest in one of corporate history's most startling downfalls. While documentaries and fringe advocacy groups continue to probe the edges of the narrative, Holmes remains behind bars. The latest demonstrations at the film festival demonstrate that the boundary between documentary filmmaking, public fascination, and eccentric activism continues to blur in the digital age.